Takeda Oncology – Individualized Cancer Care
Awny Farajallah, M.D., Head of Global Medical Affairs Oncology at Takeda, discusses his transition from physician to head of pharma medical affairs and how his unique experience working in infectious disease is advancing Takeda Oncology’s mission to provide individualized cancer care for all patients. Driven to find solutions for disenfranchised people across the globe, Dr. Farajallah’s passion closely aligns with Takeda Oncology’s values and commitment to providing patients the medicine they need, wherever they may be or whoever they may be.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Awny Farajallah, M.D. joined Takeda in July 2021 as the Head of Global Medical Affairs Oncology. He brings over 25 years of combined experience in both academic and industry settings related to clinical research/development and medical affairs across multiple therapeutic areas.
Awny joins Takeda from Ipsen, where he was Senior Vice President, Medical Affairs, North America. As a key North America Leadership Team and Global Medical Affairs Leadership Team member, Awny was responsible for providing strategic leadership and direction for all facets of the Medical Affairs organization in North America. During his tenure, Awny also led efforts to enhance Medical Affairs capabilities with the goal of broadening the impact to patients through medical stakeholder partnerships across Oncology, Neuroscience and Rare Disease.
Prior to joining Ipsen, Awny served as Vice President and Head of US Medical Affairs at Bristol Myers Squibb, where he led functions such as field medical, disease areas, medical education, biomarkers, promotional material review, portfolio strategy, as well as strategic collaborations across oncology, immunoscience, cardiovascular, neurology and mature brands. Awny has led multiple successful launches in Immuno-oncology and hematology for Opdivo ® and Yervoy ® and Sprycel ®. He also was the clinical development lead for hematological malignancies in leukemia and multiple myeloma. He also led the global medical and clinical development teams for HIV including Reyataz ® global life cycle management and business development.
Awny earned his M.D. from Cairo Univ
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
